| Effects of oral L: -carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males. | |
| | |
MedLine Citation:
|
PMID: 20963457 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Infusion of carnitine has been observed to increase non-oxidative glucose disposal in several studies, but the effect of oral carnitine on glucose disposal in non-diabetic lean versus overweight/obese humans has not been examined. This study examined the effects of 14 days of L: -carnitine L: -tartrate oral supplementation (LC) on blood glucose, insulin, NEFA and GLP-1 responses to an oral glucose tolerance test (OGTT). Sixteen male participants were recruited [lean (n = 8) and overweight/obese (n = 8)]. After completing a submaximal predictive exercise test, participants were asked to attend three experimental sessions. These three visits were conducted in the morning to obtain fasting blood samples and to conduct 2 h OGTTs. The first visit was a familiarisation trial and the final two visits were conducted 2 weeks apart following 14 days of ingestion of placebo (PL, 3 g glucose/day) and then LC (3 g LC/day) ingested as two capsules 3×/day with meals. On each visit, blood was drawn at rest, at intervals during the OGTT for analysis of glucose, insulin, non-esterified fatty acids (NEFA) and total glucagon-like peptide-1 (GLP-1). Data obtained were used for determination of usual insulin sensitivity indices (HOMA-IR, AUC glucose, AUC insulin, 1st phase and 2nd phase β-cell function, estimated insulin sensitivity index and estimated metabolic clearance rate). Data were analysed using RMANOVA and post hoc comparisons where appropriate. There was a significant difference between groups for body mass, % fat and BMI with no significant difference in age and height. Mean (SEM) plasma glucose concentration at 30 min was significantly lower (p < 0.05) in the lean group on the LC trial compared with PL [8.71(0.70) PL; 7.32(0.36) LC; mmol/L]. Conversely, plasma glucose concentration was not different at 30 min, but was significantly higher at 90 min (p < 0.05) in the overweight/obese group on the LC trial [5.09(0.41) PL; 7.11(0.59) LC; mmol/L]. Estimated first phase and second phase β-cell function both tended to be greater following LC in the lean group only. No effects of LC were observed on NEFA or total GLP-1 response to OGTT. It is concluded that LC supplementation induces changes in blood glucose handling/disposal during an OGTT, which is not influenced by GLP-1. The glucose handling/disposal response to oral LC is different between lean and overweight/obese suggesting that further investigation is required. LC effects on gastric emptying and/or direct 'insulin-like' actions on tissues should be examined in larger samples of overweight/obese and lean participants, respectively. |
| | |
Authors:
|
Stuart D R Galloway; Thomas P Craig; Stephen J Cleland |
Related Documents
:
|
11063437 - Diet-induced change in fatty acid composition of plasma triacylglycerols is not associa... 15533777 - Clinical endocrinology and metabolism. glucose-dependent insulinotropic polypeptide/gas... 17692937 - The insulinotropic effect of gip is impaired in patients with chronic pancreatitis and ... 3157397 - Lack of effect of tenoxicam on glibornuride kinetics and response. 9785467 - Islet amyloid polypeptide decreases the effects of insulin-like growth factor-i on gluc... 14518587 - The random blood glucose level, a risk factor for mortality after acute myocardial infa... |
Publication Detail:
|
Type: Journal Article Date: 2010-10-21 |
Journal Detail:
|
Title: Amino acids Volume: 41 ISSN: 1438-2199 ISO Abbreviation: Amino Acids Publication Date: 2011 Jul |
Date Detail:
|
Created Date: 2011-05-26 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9200312 Medline TA: Amino Acids Country: Austria |
Other Details:
|
Languages: eng Pagination: 507-15 Citation Subset: IM |
Affiliation:
|
Sport, Health and Exercise Sciences Research Group, University of Stirling, Stirling, FK9 4LA, Scotland, UK, s.d.r.galloway@stir.ac.uk. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Glycation in diabetic nephropathy.
Next Document: Bioconversion of L: -tyrosine to L: -DOPA by a novel bacterium Bacillus sp. JPJ.